Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) announced it has completed enrollment in BASECAMP, its Phase 2 clinical trial evaluating ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE